Key Readings in Innovative Global Health R&D Policy
Ahlén, Jonas and Peter Lundström and Josephine Rudebeck, “Innovative Finance for Health Exploring Incentives for Neglected Disease R&D.” SIDA 2009.
Anderson, Gerard F."Spurring New Research for Neglected Diseases." Health Affairs 28(6), November/December 2009.
De Ferranti, Griffin, Escobar, Glassman, and Lagomarsino. “Innovative Financing for Global Health: Tools for Analyzing the Options.” Global Health Financing Initiative, Working Paper 2, 2008, Washington: Brookings Institution.
Global Health Technologies Coalition (GHTC) fact sheet on incentives and innovative financing for global health research (available here)
Hecht, Rob and Paul Wilson and Amrita Palriwala. “Improving Health R&D Financing for Developing Countries: A Menu of Innovative Policy Options.” Health Affairs 28(4), July/August 2009.
IFPMA. “The Pharmaceutical Innovation Platform.” 2004.
Policy Cures. "Neglected Disease Research and Development: Is the Global Financial Crisis Changing R&D?" February 2011. (available here)
Trouiller, Patrice and Piero Olliaro, Els Toreele, James Orbinski, Richard Laing and Nathan Ford. “Drug Development for Neglected Diseases: A Deficient Market and a Public-Policy Failure.” Lancet 359(9324), June 2002.
WHO.“Public Health Innovation and Intellectual Property Rights.” Report on the Commission on Intellectual Property Rights, Innovation and Public Health. 2006.
WHO. "Report of the World Health Organization Expert Working Group on Research and Development Financing.” January 2010.
WHO. "First WHO Report on Neglected Tropical Diseases 2010: Working to Overcome the Global Impact of Neglected Tropical Diseases.” October 2010.